BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
78 hedge funds and large institutions have $185M invested in BioSpecifics Technologies Corp. in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 31 reducing their positions, and 17 closing their positions.
5% more capital invested
Capital invested by funds: $176M → $185M (+$9.37M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 31
11% less funds holding
Funds holding: 88 → 78 (-10)
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$8.57M |
| 2 |
Renaissance Technologies
New York
|
+$2.3M |
| 3 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$1.95M |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$1.48M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$3.5M |
| 2 |
MOACM
Mutual of America Capital Management
New York
|
-$2.4M |
| 3 |
BlackRock
New York
|
-$2.06M |
| 4 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
-$1.43M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.16M |
BSTC Hedge Fund Activity: Q1 2018 in Review
78 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2018, worth a combined $185M — up 5.3% from $176M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of BSTC and 8 opened new positions — a net loss of 9 holders — while 31 trimmed existing stakes and 28 added.
The largest buyer was Stonepine Capital Management, adding an estimated $8.57M. The largest seller was Northpointe Capital, exiting entirely with an estimated $3.5M sold.
- 78 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2018, down from 88 in Q4 2017.
- Funds reported $185M of BioSpecifics Technologies Corp. stock for Q1 2018, up 5.3% quarter-over-quarter.
- 8 funds opened new BioSpecifics Technologies Corp. positions in Q1 2018 and 17 closed out, a net change of -9 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q1 2018 was Stonepine Capital Management, an estimated $8.57M added.
- The largest BioSpecifics Technologies Corp. seller in Q1 2018 was Northpointe Capital, an estimated $3.5M sold.
Based on aggregated 13F filings for Q1 2018.